A common missense variant of LILRB₅ is associated with statin intolerance and myalgia

Moneeza K. Siddiqui, Cyrielle Maroteau, Abirami Veluchamy, Aleksi Tornio, Roger Tavendale, Fiona Carr, Ngu-Uma Abelega, Dan Carr, Katyrzyna Bloch, Par Hallberg, Qun-Ying Yue, Ewan R. Pearson, Helen Colhoun, Andrew D. Morris, Eleanor Dow, Jacob George, Munir Pirmohamed, Paul M. Ridker, Alex S. F. Doney, Ana AlfirevicMia Wadelius, Anke Hilse Maitland-van der Zee, Daniel I. Chasman, Colin N. A. Palmer (Lead / Corresponding author), PREDICTION-ADR Consortium

Population Health and Genomics

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

218 Downloads (Pure)

2 results

Filter

Finished
PREDICTION-ADR: Personalisation of tREatment In Cardiovascular Disease Through Next Generation Sequencing - Adverse Drug Reactions (Joint with University of Uppsala, University of Liverpool and University of Utrecht)
Palmer, C. (Investigator)
COMMISSION OF THE EUROPEAN COMMUNITIES
1/09/13 → 28/02/17
Project: Research
The Scottish eHealth Informatics Research Centre (E-HIRCs) (Joint with Universities of Aberdeen, Glasgow, Edinburgh, Strathclyde, St Andrews & Leicester and ISD)
Colhoun, H. (Investigator), Donnan, P. (Investigator), Guthrie, B. (Investigator), Jefferson, E. (Investigator), MacDonald, T. (Investigator), McCowan, C. (Investigator), Morris, A. (Investigator), Pearson, E. (Investigator), Sullivan, F. (Investigator) & Swedlow, J. (Investigator)
Medical Research Council
1/03/13 → 31/12/18
Project: Research

A common missense variant of LILRB5 is associated with statin intolerance and myalgia

Projects

Search results

PREDICTION-ADR: Personalisation of tREatment In Cardiovascular Disease Through Next Generation Sequencing - Adverse Drug Reactions (Joint with University of Uppsala, University of Liverpool and University of Utrecht)

The Scottish eHealth Informatics Research Centre (E-HIRCs) (Joint with Universities of Aberdeen, Glasgow, Edinburgh, Strathclyde, St Andrews & Leicester and ISD)

A common missense variant of LILRB₅ is associated with statin intolerance and myalgia